Zynex Medical, Inc.
Letter data
- Company
- Zynex Medical, Inc.
- Recipient
- Thomas Sandgaard | Founder, Chairman and CEO | Zynex Medical, Inc. | 9555 Maroon Circle | Englewood | , | CO | 80112 | United States
- Issue date
- 2018-12-18
- Posted date
- Not available
- FDA office
- Office of Medical Device & Radiological Health Operations Division 3/West
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 423378
- Reference number
- DEN-14-08-WL
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Zynex Medical, Inc.
MARCS-CMS 423378 —
December 18, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
UPS Overnight
Reference #:
DEN-14-08-WL
Product:
Medical Devices
Recipient:
Recipient Name
Thomas Sandgaard
Recipient Title
Founder, Chairman and CEO
Zynex Medical, Inc.
9555 Maroon Circle
Englewood
,
CO
80112
United States
Issuing Office:
Office of Medical Device & Radiological Health Operations Division 3/West
United States
Dear Mr. Sandgaard:
The Food and Drug Administration (FDA) has completed an evaluation of your corrective actions in response to our Warning Letter DEN-14-08-WL, dated June 27, 2014. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during subsequent inspections or through other means.
Sincerely,
/S/
Kelly Sheppard
Director, Compliance Branch
Office of Medical Device & Radiological Health Operations
Division 3/West
Content current as of:
12/31/2019
Regulated Product(s)
Medical Devices